Search research articles
Contact Us
Filters
Showing results (51-60 of 54) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 54 results.
Journal of Clinical Medicine
|
June 19, 2024
Consensus Report and Recommendations on the Management of Late-stage Internal Derangement of the Temporomandibular Joint
Florencio Monje Gil, Patricia Martínez Artal, Alberto Cuevas Queipo de Llano, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
February 8, 2025
Quality indicators of stroke care in Colombia based on the RES-Q registry
Hernán Bayona, Pablo Amaya, José Luis Bustos, et al.
The Lancet. Neurology
|
January 24, 2026
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1<sup>Glu280Ala</sup> mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
Pierre N Tariot, Francisco S Lopera, Silvia Ríos-Romenets, et al.
Frontiers in Neurology
|
October 18, 2021
Fighting Against Stroke in Latin America: A Joint Effort of Medical Professional Societies and Governments
Sheila Cristina Ouriques Martins, Pablo Lavados, Thaís Leite Secchi, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 54) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 54 results.
Journal of Clinical Medicine
|
June 19, 2024
Consensus Report and Recommendations on the Management of Late-stage Internal Derangement of the Temporomandibular Joint
Florencio Monje Gil, Patricia Martínez Artal, Alberto Cuevas Queipo de Llano, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
February 8, 2025
Quality indicators of stroke care in Colombia based on the RES-Q registry
Hernán Bayona, Pablo Amaya, José Luis Bustos, et al.
The Lancet. Neurology
|
January 24, 2026
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1<sup>Glu280Ala</sup> mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
Pierre N Tariot, Francisco S Lopera, Silvia Ríos-Romenets, et al.
Frontiers in Neurology
|
October 18, 2021
Fighting Against Stroke in Latin America: A Joint Effort of Medical Professional Societies and Governments
Sheila Cristina Ouriques Martins, Pablo Lavados, Thaís Leite Secchi, et al.
Page
of 6